Major findings and recent advances in virus–like particle (VLP)-based vaccines von Mohsen, Mona O., Zha, Lisha, Cabral-Miranda, Gustavo, Bachmann, Martin F.

Volltext

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines von Fernandes, Queenie, Inchakalody, Varghese Philipose, Merhi, Maysaloun, Mestiri, Sarra, Taib, Nassiba, Moustafa Abo El-Ella, Dina, Bedhiafi, Takwa, Raza, Afsheen, Al-Zaidan, Lobna, Mohsen, Mona O., Yousuf Al-Nesf, Mariam Ali, Hssain, Ali Ait, Yassine, Hadi Mohamad, Bachmann, Martin F., Uddin, Shahab, Dermime, Said

Volltext

Virus-like particles for vaccination against cancer von Mohsen, Mona O., Speiser, Daniel E., Knuth, Alexander, Bachmann, Martin F.

Volltext

Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor‐binding domain mutations: Receptor affinity versus neutralization of receptor interaction von Vogel, Monique, Augusto, Gilles, Chang, Xinyue, Liu, Xuelan, Speiser, Daniel, Mohsen, Mona O., Bachmann, Martin F.

Volltext

Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β von Vogt, Anne-Cathrine S, Jennings, Gary T, Mohsen, Mona O, Vogel, Monique, Bachmann, Martin F

Volltext

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System von Mohsen, Mona O, Gomes, Ariane C, Vogel, Monique, Bachmann, Martin F

Volltext

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses von Bachmann, Martin F., Mohsen, Mona O., Zha, Lisha, Vogel, Monique, Speiser, Daniel E.

Volltext

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization von Chang, Xinyue, Krenger, Pascal, Krueger, Caroline C, Zha, Lisha, Han, Jiami, Yermanos, Alexander, Roongta, Salony, Mohsen, Mona O, Oxenius, Annette, Vogel, Monique, Bachmann, Martin F

Volltext

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies von Vogt, Anne-Cathrine S, Jörg, Lukas, Martina, Byron, Krenger, Pascal S, Chang, Xinyue, Zeltins, Andris, Vogel, Monique, Mohsen, Mona O, Bachmann, Martin F

Volltext

Virus-like particle vaccinology, from bench to bedside von Mohsen, Mona O., Bachmann, Martin F.

Volltext

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine von Mohsen, Mona O, Vogel, Monique, Riether, Carsten, Muller, Julius, Salatino, Silvia, Ternette, Nicola, Gomes, Ariane C, Cabral-Miranda, Gustavo, El-Turabi, Aadil, Ruedl, Christiane, Kundig, Thomas M, Dermime, Said, Knuth, Alexander, Speiser, Daniel E, Bachmann, Martin F

Volltext

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation von Chang, Xinyue, Liu, Xuelan, Martina, Byron, Zeltins, Andris, Augusto, Gilles, Vogel, Monique, Mohsen, Mona O, Speiser, Daniel E, Bachmann, Martin F

Volltext

The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics” von Mohsen, Mona O., Augusto, Gilles, Bachmann, Martin F.

Volltext

Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis von Zha, Lisha, He, Lichun, Xie, Weidong, Cheng, Jin, Li, Tong, Mohsen, Mona O, Lei, Fan, Storni, Federico, Bachmann, Martin, Chen, Hongquan, Zhang, Yaou

Volltext

Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism von Bachmann, Martin F., Mohsen, Mona O., Speiser, Daniel E.

Volltext

Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach von Josi, Romano, Ogrina, Anete, Rothen, Dominik, Balke, Ina, Casaramona, Arnau Solé, de Brot, Simone, Mohsen, Mona O

Volltext

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate von Liu, Xuelan, Chang, Xinyue, Rothen, Dominik, Derveni, Mariliza, Krenger, Pascal, Roongta, Salony, Wright, Edward, Vogel, Monique, Tars, Kaspars, Mohsen, Mona O., Bachmann, Martin F.

Volltext

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT(R)) von Heath, Matthew D., Mohsen, Mona O., de Kam, Pieter-Jan, Carreno Velazquez, Thalia L., Hewings, Simon J., Kramer, Matthias F., Kundig, Thomas M., Bachmann, Martin F., Skinner, Murray A.

Volltext

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles von Zha, Lisha, Chang, Xinyue, Zhao, Hongxin, Mohsen, Mona O., Hong, Liang, Zhou, Yuhang, Chen, Hongquan, Liu, Xuelan, Zhang, Jie, Li, Dong, Wu, Ke, Martina, Byron, Wang, Junfeng, Vogel, Monique, Bachmann, Martin F.

Volltext

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron von Vogt, Anne-Cathrine S, Augusto, Gilles, Martina, Byron, Chang, Xinyue, Nasrallah, Gheyath, Speiser, Daniel E, Vogel, Monique, Bachmann, Martin F, Mohsen, Mona O

Volltext